(redirected from Adrenocortical carcinoma)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to carcinoma

References in periodicals archive ?
Feminizing adrenocortical carcinomas are defined as malignant tumors with estrogens overproduction with or without other adrenocortical hormones.
Results of Histopathologic Examination of Adrenal Lesions Adenoma Non-functioning benign adenoma 19 Aldosterone secreting adenoma (Conn's Syndrome) 02 Phaeochromocytoma 04 Adrenocortical carcinoma 03 Cysts Epithelial cyst 02 Endothelial cyst 03 Pseudocyst 06 Parasitic cyst 01
Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Adrenocortical carcinoma is a lynch syndrome-associated cancer.
The report provides a snapshot of the global therapeutic landscape of Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Primary non-functional extra-adrenal adrenocortical carcinoma.
Lung metastectomy also improves outcomes in urinary transitional cell carcinoma, adrenocortical carcinoma, and testicular nonseminomatous germ cell cancer (5,6,7).
Li-Fraumeni-like syndrome (LFLS): A diagnosis of any childhood cancer, sarcoma, brain tumor, or adrenocortical carcinoma in a patient younger than 45 who has one first- or second-degree relative with a LFS-associated cancer diagnosed before age 60 and another first- or second-degree relative with any type of cancer diagnosed before age 60.
Adrenocortical carcinoma with delayed cutaneous metastasis.
Washington, September 23 (ANI): Researchers are hopeful that a clinical trial of a new drug will help patients of adrenocortical carcinoma (ACC), a rare but aggressive cancer that hits the adrenal glands.
Adrenocortical carcinoma usually presents with dysfunctional uterine bleeding in women with increased amounts of androstenedione and estrogens that results in Cushing's syndrome, suggesting inefficient conversion of cortisol (4).
Survival with adrenocortical carcinoma is poor and considerable uncertainty remains as to the optimal approach for treatment when this tumor type is either still confined to the adrenal gland or when it becomes metastatic.
This report provides information on the therapeutic development for Adrenocortical Carcinoma (Adrenal Cortex Cancer), complete with latest updates, and special features on late-stage and discontinued projects.